Significance of assessing the inflammatory markers of vascular wall activation in age-related macular degeneration

Among the numerous pathogenetic factors of age-related macular degeneration (AMD), special attention has been recently paid to endothelial dysfunction (ED), since the vascular endothelium is an important internal component of the the hematoretinal barrier (IBRB) providing immunological homeostasis o...

Full description

Saved in:
Bibliographic Details
Main Authors: N. V. Balatskaya, E. P. Vorobyova, I. G. Kulikova, A. E. Andryushin
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2025-07-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/2930
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849240710071451648
author N. V. Balatskaya
E. P. Vorobyova
I. G. Kulikova
A. E. Andryushin
author_facet N. V. Balatskaya
E. P. Vorobyova
I. G. Kulikova
A. E. Andryushin
author_sort N. V. Balatskaya
collection DOAJ
description Among the numerous pathogenetic factors of age-related macular degeneration (AMD), special attention has been recently paid to endothelial dysfunction (ED), since the vascular endothelium is an important internal component of the the hematoretinal barrier (IBRB) providing immunological homeostasis of the retina. The study of inflammatory endothelial activation markers seems relevant in terms of understanding the mechanisms of disease development, potentially contributing to the development of pathogenetic therapy at early and intermediate stages of AMD as well as secondary prevention of its complications. The aim of the present: study was to determine sICAM-1, sVCAM-1, sE-selectin, sP-selectin and MCP-1/CCL2 in blood serum (BS) and tear fluid (TF) of patients with initial (AREDS2) and intermediate (AREDS3) stages of AMD. The study was performed by flow cytometry (CBA) with BD FACS Canto II flow cytometer, USA), using a diagnostic panel based on compatible simplex Flow CytomixTM test systems (Bender Med System GmbH, Germany) to determine sICAM-1, sVCAM-1, sE-selectin, sP-selectin and MCP-1/CCL2 thus allowing their simultaneous detection followed by data processing in the FlowCytomix Pro v. 6.0 package (BenderMed Systems GmbH, Germany). We have revealed a tendency to increased serum sVCAM-1 in the AREDS3 group compared to the reference values. When studying tear fluid in the AREDS2 group, a significant increase in MCP-1, sE-selectin concentrations was found (p < 0.05), along with a tendency to increased local production of sICAM-1 and sP-selectin (p = 0.05) against normal levels. Significant shifts in the AREDS3 group concerned three 3 factors in tear fluid, i.e., sICAM-1, sE-selectin and sP-selectin, that exceeded control levels by 2.5, 5 and 2 times, respectively (p < 0.05). The obtained data are important because they presume a role of sICAM-1, sVCAM-1, sE-selectin, sP-selectin, MCP-1/CCL2 in pathogenesis of the disorder and allows us to suggest a compromised state of blood retinal barrier, thus requiring supplementation of AMD therapy with angioprotectives, antiinflammatory drugs, and needs further studies.
format Article
id doaj-art-182bf7c68d99464aad9f993f68d01162
institution Kabale University
issn 1563-0625
2313-741X
language Russian
publishDate 2025-07-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj-art-182bf7c68d99464aad9f993f68d011622025-08-20T04:00:27ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2025-07-0127486387210.15789/1563-0625-SOA-29301993Significance of assessing the inflammatory markers of vascular wall activation in age-related macular degenerationN. V. Balatskaya0E. P. Vorobyova1I. G. Kulikova2A. E. Andryushin3Helmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesAmong the numerous pathogenetic factors of age-related macular degeneration (AMD), special attention has been recently paid to endothelial dysfunction (ED), since the vascular endothelium is an important internal component of the the hematoretinal barrier (IBRB) providing immunological homeostasis of the retina. The study of inflammatory endothelial activation markers seems relevant in terms of understanding the mechanisms of disease development, potentially contributing to the development of pathogenetic therapy at early and intermediate stages of AMD as well as secondary prevention of its complications. The aim of the present: study was to determine sICAM-1, sVCAM-1, sE-selectin, sP-selectin and MCP-1/CCL2 in blood serum (BS) and tear fluid (TF) of patients with initial (AREDS2) and intermediate (AREDS3) stages of AMD. The study was performed by flow cytometry (CBA) with BD FACS Canto II flow cytometer, USA), using a diagnostic panel based on compatible simplex Flow CytomixTM test systems (Bender Med System GmbH, Germany) to determine sICAM-1, sVCAM-1, sE-selectin, sP-selectin and MCP-1/CCL2 thus allowing their simultaneous detection followed by data processing in the FlowCytomix Pro v. 6.0 package (BenderMed Systems GmbH, Germany). We have revealed a tendency to increased serum sVCAM-1 in the AREDS3 group compared to the reference values. When studying tear fluid in the AREDS2 group, a significant increase in MCP-1, sE-selectin concentrations was found (p < 0.05), along with a tendency to increased local production of sICAM-1 and sP-selectin (p = 0.05) against normal levels. Significant shifts in the AREDS3 group concerned three 3 factors in tear fluid, i.e., sICAM-1, sE-selectin and sP-selectin, that exceeded control levels by 2.5, 5 and 2 times, respectively (p < 0.05). The obtained data are important because they presume a role of sICAM-1, sVCAM-1, sE-selectin, sP-selectin, MCP-1/CCL2 in pathogenesis of the disorder and allows us to suggest a compromised state of blood retinal barrier, thus requiring supplementation of AMD therapy with angioprotectives, antiinflammatory drugs, and needs further studies.https://www.mimmun.ru/mimmun/article/view/2930age-related macular degenerationvascular endothelialdysfunctioninflammationmarkersadhesion moleculeschemokines
spellingShingle N. V. Balatskaya
E. P. Vorobyova
I. G. Kulikova
A. E. Andryushin
Significance of assessing the inflammatory markers of vascular wall activation in age-related macular degeneration
Медицинская иммунология
age-related macular degeneration
vascular endothelial
dysfunction
inflammation
markers
adhesion molecules
chemokines
title Significance of assessing the inflammatory markers of vascular wall activation in age-related macular degeneration
title_full Significance of assessing the inflammatory markers of vascular wall activation in age-related macular degeneration
title_fullStr Significance of assessing the inflammatory markers of vascular wall activation in age-related macular degeneration
title_full_unstemmed Significance of assessing the inflammatory markers of vascular wall activation in age-related macular degeneration
title_short Significance of assessing the inflammatory markers of vascular wall activation in age-related macular degeneration
title_sort significance of assessing the inflammatory markers of vascular wall activation in age related macular degeneration
topic age-related macular degeneration
vascular endothelial
dysfunction
inflammation
markers
adhesion molecules
chemokines
url https://www.mimmun.ru/mimmun/article/view/2930
work_keys_str_mv AT nvbalatskaya significanceofassessingtheinflammatorymarkersofvascularwallactivationinagerelatedmaculardegeneration
AT epvorobyova significanceofassessingtheinflammatorymarkersofvascularwallactivationinagerelatedmaculardegeneration
AT igkulikova significanceofassessingtheinflammatorymarkersofvascularwallactivationinagerelatedmaculardegeneration
AT aeandryushin significanceofassessingtheinflammatorymarkersofvascularwallactivationinagerelatedmaculardegeneration